SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cancer Patients’ Trade-offs Among Efficacy, Toxicity, and Out-of-Pocket Cost in the Curative and Noncurative Setting
11 references·0 citing·50 second hop
Cancer Patients’ Trade-offs Among Efficacy, Toxicity, and Out-of-Pocket Cost in the Curative and Noncurative Setting (2013)Cancer Patients’ Trade-offs Among Efficac…The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)The Financial Toxicity of Can…How Cancer Patients Value Hope And The Implications For Cost-Effectiveness Assessments Of High-Cost Cancer Therapies (2012)How Cancer Patients Value Hop…Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions (2011)Patient and Plan Characterist…Discrete choice experiments in health economics: a review of the literature (2010)Discrete choice experiments i…American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)American Society of Clinical …Prescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007)Prescription drug cost sharin…Medical Oncologists' Views on Communicating With Patients About Chemotherapy Costs: A Pilot Survey (2007)Medical Oncologists' Views on…Patient Preferences and Health Disparities (2001)Patient Preferences and Healt…Using conjoint analysis to elicit preferences for health care (2000)Using conjoint analysis to el…Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. (1985)Optimism, coping, and health:…Some Interim Results from a Controlled Trial of Cost Sharing in Health Insurance (1981)Some Interim Results from a C…Simultaneous conjoint measurement: A new type of fundamental measurement (1964)Conditional logit analysis of qualitative choice behavior (1972)Combining Revealed and Stated Preference Methods for Valuing Environmental Amenities (1994)Discrete choice experiments in health care (2004)Economic valuation of informal care (2004)Conjoint Analysis Applications in Health – How are Studies being Designed and Reported? (2010)Effects of Socioeconomic Status on Access to Invasive Cardiac Procedures and on Mortality after Acute Myocardial Infarction (1999)Race, Socioeconomic Status, and Health The Added Effects of Racism and Discrimination (1999)Inequality in Quality (2000)Who You Are And Where You Live: How Race And Geography Affect The Treatment Of Medicare Beneficiaries (2004)Recommendations for Teaching about Racial and Ethnic Disparities in Health and Health Care (2007)Measuring Racial/Ethnic Disparities in Health Care: Methods and Practical Issues (2012)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia (2013)The High Cost of Prescription Drugs in the United States (2016)Prospect Theory: An Analysis of Decision under Risk (1979)Prospect theory: An analysis of decision under risk (1988)Preserving the Physician-Patient Relationship in the Era of Managed Care (1995)Understanding Patients' Attitudes Toward Communication About the Cost of Cancer Care (2012)A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment (2016)Financial Toxicity in Adults With Cancer: Adverse Outcomes and Noncompliance (2018)Mixed Logit with Repeated Choices: Households' Choices of Appliance Efficiency Level (1998)Stated Choice Methods (2000)Applied Choice Analysis (2005)Discrete Choice Experiments in Health Economics: A Review of the Literature (2014)Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide (2015)Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force (2016)Celebrating the New (2008)Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study (2015)Financial toxicity and implications for cancer care in the era of molecular and immune therapies (2018)The Patient Protection and Affordable Care Act (2018)Society and the Adolescent Self-Image (1965)Generalized expectancies for internal versus external control of reinforcement. (1966)A Global Measure of Perceived Stress (1983)Subjective well-being: Three decades of progress. (1999)Individual differences in two emotion regulation processes: Implications for affect, relationships, and well-being. (2003)The benefits of being present: Mindfulness and its role in psychological well-being. (2003)Medical Care Costs: How Much Welfare Loss? (1992)Estimating The Cost Of New Drug Development: Is It Really $802 Million? (2006)Association of Insurance with Cancer Care Utilization and Outcomes (2008)Risk Factors for Financial Hardship in Patients Receiving Adjuvant Chemotherapy for Colon Cancer: A Population-Based Exploratory Analysis (2012)For Working-Age Cancer Survivors, Medical Debt And Bankruptcy Create Financial Hardships (2016)Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)Payment Restrictions for Prescription Drugs under Medicaid (1987)A Microeconometric Model of the Demand for Health Care and Health Insurance in Australia (1988)The logged dependent variable, heteroscedasticity, and the retransformation problem (1998)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer (2016)Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)
this work references cited by second hop

References

  • 1985Optimism, coping, and health: Assessment and implications of generalized outcome expectancies.6,685 cited
  • 2010Discrete choice experiments in health economics: a review of the literature1,327 cited
  • 2013The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience1,133 cited
  • 2000Using conjoint analysis to elicit preferences for health care939 cited
  • 2007Prescription drug cost sharing: associations with medication and medical utilization and spending and health.875 cited
  • 2009American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care638 cited
  • 1981Some Interim Results from a Controlled Trial of Cost Sharing in Health Insurance559 cited
  • 2011Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions249 cited
  • 2007Medical Oncologists' Views on Communicating With Patients About Chemotherapy Costs: A Pilot Survey194 cited
  • 2001Patient Preferences and Health Disparities177 cited
  • 2012How Cancer Patients Value Hope And The Implications For Cost-Effectiveness Assessments Of High-Cost Cancer Therapies128 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work